openPR Logo
Press release

Personalized Cancer Vaccines Market Personalized Cancer Vaccines Clinical Pipeline Report 2022

07-11-2017 11:15 AM CET | Health & Medicine

Press release from: Kuick Resarch

Personalized Cancer Vaccines Market Personalized Cancer

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

Report Table of Contents

1. Personalized Vaccine: Trail Towards Cancer
1.1 Prologue to Personalized Cancer Immunotherapy
1.2 Advent of Personalized Cancer Vaccine

2. Perception of Personalized Vaccinomics
2.1 Genetic Heterogeneity by HLA System
2.2 Genesis of Tumor Neoantigens

3. Identification of Tumor Neoantigens
3.1 Conventional Methodologies
3.2 Next Genome Sequencing Approach

4. Development of Personalized Vaccines
4.1 Development Process of Personal Cancer Vaccine
4.2 Economic Aspects of Personalized Cancer Vaccine

5. Mechanism of Personalized Vaccines
5.1 Rationale of Personal Cancer Vaccine
5.2 Neoantigens and Immune Interactions

6. Application of Neoantigens in Therapeutics
6.1 Adoptive T Cell Therapy
6.2 Checkpoint Blockade

7. Categories of Personalized Cancer Vaccines
7.1 Personalized Peptide Vaccination (PPV)
7.2 DNA Cancer Vaccines
7.3 RNA Based Vaccines
7.4 Dendritic Cell Vaccines
7.5 Whole Tumor Cell Vaccines
7.6 Recombinant Virus Vaccines


8. Biomarkers for Personalized Vaccines
8.1 Pharmacogenomic Biomarkers
8.2 Prognostic and Predictive Biomarkers
8.3 Immune Checkpoint Biomarkers

9. Personalized Vaccines for Varied Cancers
9.1 Melanoma
9.2 Lung Cancer
9.3 Breast Cancer
9.4 Colorectal Cancer
9.5 Leukemia
9.6 Prostate cancer
9.7 Cervical Cancer
9.8 Gastric Cancer
9.9 Brain Tumor
9.10 Renal Cancer

10. Pharmacogenomics of Personalization
10.1 Pharmacogenomics towards Genomic Polymorphism
10.2 Somatic Mutations in Cancer Pharmacogenomics
10.3 Applications of Pharmacogenomics

11. Personalized Vaccines Market Overview
11.1 Market Trends Towards Therapeutic Personalization
11.2 Mergers and Acquisitions for Personalized Therapy

12. Global Personalized Vaccines Market Dynamics
12.1 Personalization Growth Drivers
12.1.1 Increasing Cancer Incidences
12.1.2 Cancer Heterogenetic Environment
12.1.3 High Level of Specificity
12.1.4 Government Initiatives
12.1.5 Reduced Genome Sequencing Cost and Time
12.1.6 Sustained Level of Innovation
12.2 Personalization Major Challenges

13. Global Personalized Cancer Vaccines Market Future Aspects

14. Competitive Landscape
14.1 Advaxis Inc.
14.2 Avax Technologies
14.3 BioNtech
14.4 Celldex
14.5 Genentech Inc.
14.6 Genocea
14.7 ISA Pharmaceuticals
14.8 Merck and Co.
14.9 Moderna
14.10 Neon Therapeutics

Download Report: https://www.kuickresearch.com/report-personalized-cancer-vaccines-market-and-clinical-innovation-outlook-2022.php

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Cancer Vaccines Market Personalized Cancer Vaccines Clinical Pipeline Report 2022 here

News-ID: 618580 • Views: 348

More Releases from Kuick Resarch

Lumakras Drug Clinical Insight and Sales Forecast 2026
"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) * Pharmacokinetics of Lumakras (Sotorasib) * Dosage, Patent and Price Analysis * Lumakras Ongoing Clinical Trials * Global KRAS Protein Inhibitors Clinical Trials Download Report: https://www.kuickresearch.com/report-lumakras-sotorasib-sales-forecast-fda-approved-kras-inhibitor-clinical-trials-non-small-cell-lung-cancer-nslc-g12c-mutation-c30h30f2n6o3-ras-gtpase The rising burden of cancer and the increasing cancer mortality rates possesses an unmet need for the development of novel therapies in the management
Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026
"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik (Tazemetostat) First Approved EZH2 Inhibitor Drug * Dosage, Price and Sales Analysis of Tazverik * Tazverik Sales Opportunity > US$ 900 Million by 2026 * Tazverik Sales Forecast 2021 Till 2026 * EZH2 Inhibitor Clinical Pipeline Overview By Company, Indication and Phase * EZH2 Inhibitor in Clinical Trials: 7 Drugs Download
Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …
"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion * Global Bispecific Antibody Market Growth Rate: 100% CAGR (2016 -2021) * Approved Bispecific Antibodies In Market: 4 Antibodies * Detailed Market Sales and Trends Insight Till 2028 * Quarterly and Yearly Sales Insight Of Approved Antibodies Till Q1 2022 * Global and Regional Market Analysis * Approved Drug Sales
Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …
"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion by 2026 * Role of FGFR Inhibitors in Cancer Therapy * Global FGFR Market Assessment (US$) by Region and Cancer Type Clinical and Sales Insight on Approved FGFR Inhibitors: 3 (Belvesra, Pemazyre and Truseltiq) * Dosage and Drug Price Insight on Approved FGFR Inhibitors * Comprehensive Clinical Trials Insight

All 5 Releases


More Releases for Personal

Personal Trainers Market Seeking Excellent Growth | Kinetic Personal Training, T …
Latest Study on Industrial Growth of Global Personal Trainers Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Personal Trainers market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and
Personal Protective Equipment Market Size, Share | Personal Protective Equipment …
Global Personal Protective Equipment Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Personal Protective Equipment Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization,
Personal Finance Apps Market is Thriving Worldwide with Mint, Personal Capital, …
Global Personal Finance Apps Market Size, Status and Forecast 2018-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The influencing Factors of growth and regulations with respect to the usage of the information, availability of highly reliable products in the market, and increase in operational efficiency of Personal Finance Apps Players.The study provides information
Blast Auxillary Personal Fan Review: Shocking Truth About The Blast Personal Fan …
Blast Auxiliary Personal Fan is a new technology that has been introduced with the aim of helping people get through the nasty summer heat. According to the official website, this portable cooling fan can be carried anywhere with ease, even outdoors, this is to ensure that you keep your body temperature cool even when it’s boiling outside. Last summer, I was transferred to Arizona to handle a project. It was my
Personal Services Market
Personal Services Market Global Briefing 2017 Personal Services market global briefing provides strategists, marketers and senior management with the critical information they need to assess the global personal services sector. Reasons to Purchase: • Outperform competitors using accurate up to date demand-side dynamics information. Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Develop strategies based on likely future developments. • Suitable for
Homeowner Insurance Market For Dwelling, Personal Property, Loss of use, Persona …
MarketResearchReports.Biz adds “Global Homeowner Insurance Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Homeowner Insurance market and the growth estimates for the forecasted period. The Homeowner Insurance Market has been comprehensively detailed in the report with special focus on a range of key elements such as market share, forecast and base figures, CAGR, driving factors, growth restraints, and